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Supplementary material A: Data collection and statistical analysis 
 
IBBA surveys 
The integrated biological and behavioural assessments (IBBAs) are surveys which were specifically 
designed for the evaluation of Avahan, including the impact analysis and mathematical modelling 
described in this work. They consist of anonymised cross-sectional random samples of female sex 
workers (FSWs), their clients, and men who have sex with men (MSM) in twenty four districts in four 
southern states of India (Andhra Pradesh, Karnataka, Maharashtra, Tamil Nadu). The surveys used 
traditional cluster (for stable populations such as home- or brothel-based FSWs) and time location 
clusters (for mobile populations such as street-based FSWs) sampling, based on detailed mapping of 
target populations in each district.1 They were carried out as face-to-face interviews, using a 
culturally sensitive and context-specific questionnaire translated into the local languages, along with 
the collection of blood samples to test for HIV, HSV-2 and syphilis. The sample size was normally 
about 400 respondents for each studied risk group in each district. IBBA districts were chosen based 
on socio-cultural regions and estimated size of the FSW population:2 districts with larger estimated 
FSW populations were chosen in each local socio-cultural region, as well as all four state capitals. 
There was no prior targeted HIV intervention in only 6 of the 24 IBBA districts, while across the 69 
Avahan districts there were 29 districts with no prior intervention. This was because districts with 
larger known FSW populations, which tended to already have interventions, were selected for IBBA 
surveys. Since condom use would be expected to be lower in districts without pre-existing 
interventions, this suggests that intervention impact may be underestimated, although a variable 
describing whether Avahan was the main intervention provider in the first year was included in the 
statistical model to extrapolate impact to non-IBBA Avahan districts. 
Intervention activities were initiated in each IBBA district between January 2004 and July 2005, with 
the first FSW IBBA round conducted up to 25 months after the start of programme activities. While 
hand-over of intervention activities to the Indian government began in 2008 in Avahan districts, in 
all IBBA districts except Chennai, the last IBBA rounds were conducted before the start of the hand-
over in that district. A full list of programme start dates and IBBA survey dates is given in Appendix 
Table 1.  
Serum for HIV testing was stored at -20°C, and dried blood spots for HIV testing were stored at 4°C. 
HIV serological testing used a synthetic peptide enzyme immunoassay (in Karnataka Detect HIV 1/2 
system, BioChem ImmunoSystems, Montreal, Canada; outside Karnataka Microelisa, J. Mitra and 
Company, India), and positive tests were confirmed using a recombinant antigen enzyme 
immunoassay (Genedia HIV 1/2 ELISA 3.0; Green Cross Life Science Corporation, South Korea). In 
Karnataka, when serum samples were not provided, the serological tests were carried out on dried 
blood spots obtained from on finger prick blood and when neither serum nor finger prick samples 
were provided, urine samples were tested for HIV by enzyme immunoassay (Calypte Biomedical 
Corporation, Berkeley, California, USA) and confirmed by Western blot (Calypte Biomedical 
Corporation). Within Karnataka, serological testing for HSV-2 was carried out using an IgG enzyme 
immunoassay (Kalon Biological Ltd., Aldershot, UK) on all individuals in the survey for those rounds 
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when it was tested. Outside Karnataka, HSV-2 ELISA was performed on a 10% subset of all serum 
samples using HerpSelect 2 ELISA IgG kits (Focus Diagnostics). Serological testing for syphilis used the 
rapid plasma reagin (RPR) method (Span Diagnostics, Sachin, India), and if positive, confirmation was 
by the Treponema pallidum haemagglutination assay (TPHA) test (Omega Diagnostics Ltd., Alloa, 
Scotland). Syphilis infection was defined as being RPR positive (any titre) and TPHA positive. High-
titre syphilis was defined as having an RPR titre of 1:8 or higher and being TPHA positive. All positive 
specimens and 10% of negative specimens were sent to the National AIDS Research Institute (NARI) 
in Pune, India, for quality assurance.  
SBS surveys 
The special behavioural surveys (SBSs) were anonymised behavioural surveys of cross-sectional 
random samples of FSWs and MSM. Unlike the IBBAs, no biological sample was taken. The FSW SBS 
surveys were carried out in Bangalore urban, Belgaum, Bellary, Guntur, Mysore, and Mumbai where 
surveys were done separately for brothel-based and street-based FSWs. For MSM, there were SBS 
surveys in Bangalore, Guntur, Mysore, and Mumbai. The surveys used the same sampling methods 
as the IBBAs, with traditional cluster (for stable populations such as home- or brothel-based FSWs) 
and time location clusters (for mobile populations such as street-based FSWs) sampling. The surveys 
were administered face-to-face in the local languages. In most districts the sample size for each 
survey was around 200 individuals. The exceptions were Mysore MSM (n=75) and Bangalore where 
both the FSW and MSM surveys had approximately 370 respondents. FSW SBS surveys were carried 
out between February 2006 and December 2007, while MSM SBS surveys were undertaken between 
July 2006 and May 2008. 
GPS surveys 
General population surveys (GPSs) were carried out either as face-to-face interviews or using a 
polling booth methodology described below. In each case, a two-stage stratified cluster sampling 
method was used, to select first rural villages and urban blocks, which formed the primary sampling 
units (PSUs), and then individuals from within the PSUs. Eligible individuals were aged 15-49 years, 
usual residents of the household, and had stayed within the household the night before. This list was 
stratified by sex, age and marital status, and the required number of individuals in each PSU was 
selected systematically with probability proportionate to size. GPS surveys were carried out in 2005 
in Guntur, and in 2006-8 in the other districts. 
GPS face-to-face interview surveys, with a target sample size of 6000 individuals, were carried out in 
Mysore, Belgaum, Bellary, and Guntur districts as face-to-face interviews in the local language, using 
different questionnaires for men and women. Urine and blood specimens were collected from all 
consenting participants. These were subsequently anonymously tested for antibodies to HIV, HSV-2 
and syphilis.  
General population polling booth surveys (GPS PBS) were carried out in Mysore, Belgaum and Bellary 
districts with a target sample size of 3000 individuals in each district. Biological samples were not 
taken from GPS PBS respondents. For each PBS session, consenting participants were gathered 
together into separate groups of 8-20 unmarried and married men and women. Each participant had 
a private booth allocated to them, so that the inside of the booth was visible only to themselves. 
Coloured containers marked ‘yes’ and ‘no’ were placed inside each box. Respondents were provided 
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with sets of standard ‘voting’ tokens, each one marked only with a different question number, with 
no identifying number or other mark to distinguish participants. Questionnaires were specifically 
designed for each of the four demographic groups, and questions were read out aloud by the 
interviewer in the local language. Participants answered by putting their numbered voting token in 
colour-coded boxes, with the different colours corresponding to whether they answered ‘yes’ or ‘no’ 
to that question. 
Ethical considerations 
The IBBA studies were approved by the ethics committees of all institutes that were involved in the 
data collection: the National AIDS Research Institute, Pune (Maharashtra), the National Institute of 
Epidemiology, Chennai (Tamil Nadu), the National Institute of Nutrition, Hyderabad (Andhra 
Pradesh), and St. John’s Medical College, Bangalore (Karnataka), India, as well as Family Health 
International, Arlington, VA, USA, and the University of Manitoba, Winnipeg, Canada. The GPS and 
SBS studies were approved by the ethics committees of the Centre hospitalier affilié universitaire de 
Québec, Québec, Canada and the University of Manitoba, Winnipeg, Canada. The GPS and SBS 
carried out in Karnataka states have additionally been approved by the ethics committees of St. 
John’s Medical College, Bangalore, India, while the GPS carried out in Guntur district was additionally 
approved by the ethics committees of the Public Health Foundation of India, New Delhi and Nizam’s 
Institute of Medical Sciences, Hyderabad, India. The SBS carried out in Mumbai was additionally 
approved by the ethics committee of the Tata Institute of Social Sciences, Mumbai, India, while the 
one carried out in Guntur district was also approved by the ethics committee of the Centre for 
Media Studies, New Delhi, India. Finally, statutory approval for the conduct of all these studies and 
their protocols was obtained from the Government of India’s Health Ministry Screening Committee 
(HMSC). 
Model parameterisation 
Biological parameter ranges for the mathematical model were obtained from literature. Full lists of 
these parameters and the corresponding references, as well as non-district specific behavioural 
parameters are given in Appendix Tables 2-3.  
Ranges for district-specific parameters derived from the IBBA surveys are given in Appendix Tables 4-
11. The HIV and STI prevalence ranges from IBBA surveys, which were used to fit the model as 
described later, are given in Appendix Tables 13-14. 
Statistical analysis 
Statistical analysis for the district-specific parameters derived from IBBA surveys were performed 
using the survey methods in STATA, version 11.0,3 except where stated otherwise, to take into 
account the weights (due to non-response and the differential recruitment of FSW by typology 
within each district) and the correlated nature of the data due to the cluster sampling.4  
Respondents who participated in more than one survey round were included in all analyses, because 
as a result of the unlinked, anonymous nature of the surveys it was not possible to know which of 
the respondents in round 1 corresponded to a repeat respondent in later rounds.  
Three districts had two or more FSW IBBA surveys in each round, sampling different risk groups. In 
Mumbai there were separate surveys of brothel-based FSWs, street-based FSWs and bar girls. In 
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Pune there were surveys for brothel-based and non-brothel-based FSWs, while in Thane there were 
surveys of brothel and street-based FSWs. In each case the prior range for each parameter derived 
from the FSW IBBA was a weighted average of the different surveys, using the proportion of the FSW 
population in each group based on the FSW size mapping estimates (Appendix Table 12). In Mysore, 
Belgaum, Bellary and Shimoga, joint MSM IBBAs were carried out combining districts, and the 
district-level model-parameters were obtained by restricting respondents to the relevant district. In 
Chennai, two separate MSM IBBAs were carried out, for aravani (a regional term referred to as hijra 
elsewhere) and non-aravani MSM, and as for FSWs the prior range for each parameter was a 
weighted range of each parameter (15% aravani, 85% other). In Mumbai and the adjoining district of 
Thane, combined MSM IBBAs were also carried out. However, size mapping estimates indicated that 
the high-risk MSM population based in Thane was around 100 individuals in total, and thus for the 
modelling the MSM population in Thane was set to zero for simplicity. 
Statistical analysis for HIV trends: 
Between the first two rounds of the FSW IBBA, in some districts there were significant changes in 
certain variables such as FSW typology (whether the FSW was brothel-based, street-based, home-
based or other), mean age, literacy and marital status, which were known to be associated with HIV 
prevalence. To deal with this, the first round was used as a fixed baseline for fitting, and then the risk 
(prevalence) ratio was calculated for fitting subsequent rounds in order to be able to adjust for 
changing risk factors as described below. Since both condom use and the number of clients were 
allowed to vary between rounds, these were not adjusted for. 
To estimate the slope of the change in HIV prevalence from the first to the second IBBA survey 
round (and first to third when relevant), risk (prevalence) ratios were calculated, using multivariable 
analysis. Unexponentiated regression coefficients provided estimates of the slopes. A risk ratio is a 
ratio of the probability of the event occurring in the exposed group versus in the non-exposed group, 
while a risk difference describes the absolute change in risk in the exposed group versus in the non-
exposed group.5 We used SAS proc genmod (SAS version 9.1.3) for all analysis.6 Multivariable models 
(both prevalence ratio and difference models) were adjusted for a number of key variables for each 
district, subject to availability from surveys conducted in that district including: typology (place of 
solicitation), age, marital status, education, duration of sex work, ever asked for anal sex and 
whether or not the respondent was born in the town of interview. If the multivariable model did not 
converge, then variables were included based on an order of preference chosen a priori based on 
perceived importance of the variable to the mathematical model. Thus, the final set of variables in 
the multivariable models may differ across districts. Appendix Table 14 lists the variables used in the 
multivariable models for each district, and the corresponding adjusted prevalence ratios. 
Condom reconstruction analysis 
Since there were no baseline surveys of FSW or MSM behaviour, a historical cohort method 
described in reference 7 was used to derive time trends for condom use for each of these groups 
prior to the first IBBA round. For simplicity we describe how the method was applied for FSWs, 
although the same technique was used for MSM. 
For each district, the FSW CCU level at the start of Avahan was the percentage of FSWs who 
reported using condoms consistently out of all those who reported having sold sex at that time, thus 
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excluding those who were not selling sex at that time from the denominator. The rate of increase in 
CCU of FSWs prior to the start of the intervention was derived from the estimated CCU time trends 
analysis based on the historical FSW cohort data as explained in Lowndes et al.7 of the average 
annual change in condom use during the period 1998-2003 representing the time period before the 
start of the intervention. This was then combined with the level at the start of Avahan to give 
projections of condom use over time prior to the start of Avahan. 
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Supplementary material B: Mathematical modelling 
The overall model used is formed of two components which simulate high-risk groups (“high-risk 
model component”) and the general population (“general population model component”) 
respectively. The former consists of a set of deterministic ordinary differential equations which are 
solved numerically using the C programming language and Runge-Kutta methods, and it models the 
transmission of HIV, HSV-2 and syphilis amongst FSWs, their clients and MSM. The latter component 
models downstream HIV and HSV-2 infection to non-commercial partners of clients and MSM, as 
well as former high-risk men, using an individual-based structure developed in the Python 
programming language. Rates of infection, disease progression and death were passed from the 
high-risk model component to the general population model component to update the disease state 
of the high-risk partner in the latter model component. 
Since rates of other bacterial STIs apart from syphilis were found to be low in surveys, and had a 
negligible effect on an earlier modelling analysis,8 they were excluded from the current model. 
Similarly as injecting drug use is not a prevalent risk factor in South India,9 this was excluded from the 
model for simplicity. 
High-risk model component 
Behavioural structure 
The high-risk model component was highly stratified to give the model sufficient heterogeneity to be 
able to reproduce the rapid initial rise in HIV prevalence among FSWs, and thus fit the range of HIV 
epidemics observed across IBBA districts which was not possible with the simpler models tested 
during the development stage. Where possible the chosen stratifications reflect factors which were 
known or found to be risk factors for HIV infection across IBBA rounds.  
FSWs were divided into 24 subgroups stratified by the length of time spent selling sex (0-1, 2-4, 5-9, 
10+ years), level of consistency of condom use (“high”, “medium”, “low”) and activity level (whether 
they had above the median number of clients or not). Clients were divided into 8 subgroups 
according to the length of time they had been buying sex (0-1, 2-4, 5-9, 10+ years) and activity level 
(similarly defined by whether their number of visits to FSWs per month was higher the median or 
not). In India, MSM have different identity groups, and within the model MSM were divided into 
“high-risk” and “low-risk” MSM according to these identities as described in more detail below. 
Upon ceasing high-risk behaviour (defined as buying/selling sex or being MSM) individuals leave 
their high-risk group at rates dependent on their activity level (for FSWs/clients) or risk level (for 
MSM) and are replaced by uninfected new individuals at a rate, so as to maintain the proportion of 
the general population who are at high-risk at a constant level. Individuals who were HIV positive and 
ceased high-risk behaviour continued to be included in the general population model component 
each month, so as to include potential subsequent HIV transmission to their partners. 
MSM stratification 
In India, there are different identity groups among MSM and transgenders. Within the model, they 
were divided into a group of MSM and transgenders (“high-risk MSM”) who typically sell sex, have 
high numbers of commercial and casual partnerships, and usually take the receptive role in sex, and 
a group of MSM (“low-risk MSM”) who tend to buy sex, have fewer MSM partnerships, and generally 
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take the insertive role, based on literature of MSM in the region.10 Both high and low-risk MSM 
reported in surveys having long-term female partners or visiting FSWs, and thus these partnerships 
were included in the model, with high-risk MSM having a lower rate of both types of female partners 
based on the district-level IBBA surveys. In districts where there was no MSM IBBA, the number of 
MSM in the model was set to zero, so as to not model MSM within those districts, and the impact on 
MSM in these districts was then derived using a regression analysis as described in the main paper. 
Sexual partnerships 
Relationships between FSWs and clients were either occasional, regular (lasting years) or long-term. 
There is little data on the identity of long-term non-commercial partners of FSWs, but as their risk of 
infection is high they were included with clients. From IBBA data, clients reported repeated visits to 
some FSWs (“regular”), as well as one-off or short-term visits (“occasional”). Regular partnerships 
could last several years, and survey data suggests that regular clients would typically visit once a 
week. A list of the parameters used for these partnership durations is given in Appendix Table 3, 
while Appendix Table 8 and 9 give the number of commercial partnerships between FSWs and 
clients. Appendix Table 5 gives the parameters related to non-commercial partnerships between 
FSWs and clients. 
Proportionate mixing for each type of FSW-client partnership was assumed, whereby individuals 
choose different types of partner in proportion to their availability. The number of FSWs/clients 
visited per month by clients varied by activity level of the client/FSW. In both cases these choices of 
dependence were made to maximise behavioural heterogeneity between groups. FSW sexual 
activity and population size determined the number of partnerships available, which was in turn 
used to determine the client size population. 
MSM formed short-term partnerships with other MSM, and proportions of each MSM group also 
visited FSWs and had long-term male or female partners. All the ranges for these parameters were 
derived from the IBBA survey data and shown in Appendix Table 10.  
There is limited information available on how MSM mix, although the exact pattern of mixing 
between MSM has been shown to make little differences to impact estimates for interventions 
targeting high-risk MSM.11 Based on discussions with experts in the area, we therefore assumed that 
the majority of high-risk MSM partnerships were with low-risk MSM, and that the majority of low-
risk MSM partnerships were with high-risk MSM, and that in partnerships between MSM in different 
risk groups that the high-risk MSM would take the receptive role. We also assumed that the role 
taken was fixed for that partnership, and therefore constructed two mixing matrices, one for 
receptive partnerships and one for insertive partnerships with the constraint that for every 
combination of risk groups A and B the number of insertive partnerships of the group A with group B 
must equal the number of receptive partnerships of group B with A.  
Based on available survey data, a limited percentage (0-20%) of all high-risk MSM receptive 
partnerships were with other high-risk MSM (denoted x) so that the latter MSM took the insertive 
role, while 0-20% of low-risk MSM insertive partnerships were with other low-risk MSM (denoted y) 
who would then take the receptive role. Under the further assumptions that low-risk MSM only have 
receptive sex with other low-risk MSM, and that high-risk MSM only have insertive sex with other 
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high-risk MSM, the mixing matrices for insertive and receptive partnerships are (where index 1 is 
low-risk and 2 is high-risk, and x and y are defined as above): 
     (
  
    
) and      (
    
  
). 
Long-term MSM partnerships were assumed to be assortative for simplicity, with half of all acts for 
each partner being insertive. The limited survey data on this subject suggested that large fractions of 
high-risk MSM have either mainly insertive or both insertive and receptive sex with their long-term 
partners while low-risk MSM have either mainly receptive or both insertive and receptive sex with 
their long-term partners, implying that neither group was forming partnerships where the partner 
was clearly more masculine/effeminate and thus they were likely to belong to the same risk group as 
the risk group is itself a proxy for MSM sexual identity. 
Estimates for the size of the high-risk MSM population (        came from the MSM population 
size mapping estimates carried out by Avahan. Ranges for the low-risk MSM population (        
were based on the percentage (1·3-3·4%) of all general population men who reported ever having 
had anal sex with a man, using the polling booth methodology12 to reduce social desirability bias and 
the range from Verma et al.13 Allowance was also made for the fact that based on the responses 
from average low-risk MSM surveyed in the IBBA, these MSM typically ceased MSM activity after 11-
15 years. 
The rate of receptive and insertive partnership formation for each MSM risk group was then derived 
algebraically to be: 
      
          
 
       
    
 
      
          
    
   
       
    
 
      
          
      
      
    
   
    
   
 
      
          
       
    
where for example     
    is the (i,j)th element of the matrix     . 
All long-term and regular partnerships between FSWs and clients, and between high-risk men, were 
assumed to be of finite duration, as given in Appendix Tables 5 and 10 respectively. 
Biological structure and syphilis treatment 
The biological structure of the model is described in detail in reference 14. A full list of the biological 
parameter ranges used is given in Appendix Table 2. Briefly, the model incorporated 3 stages of HIV 
infection with increased HIV transmission during early and late infection. Co-circulating HSV-2 
infection was modelled with a short initial period of high infectivity, followed by a long 
asymptomatic phase with low-level infectious shedding, and infectious symptomatic recurrences. 
There were cofactors facilitating HIV and HSV-2 acquisition and transmission, as well as higher rates 
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of symptomatic recurrences of HSV-2 in HIV positive individuals, reflecting the synergy between 
these infections.15-17  
The natural history of syphilis was modelled dynamically with primary and secondary infection 
stages followed by a latent phase with infrequent recurrences of secondary syphilis,18 using the 
same behavioural structure as for HIV/HSV-2, and taking into account HIV deaths so as to give an 
average cofactor for increasing HIV susceptibility for each behavioural compartment. It was assumed 
that all individuals with syphilis receive treatment/recover before or during the latent stage, and so 
would not develop tertiary syphilis. Upon treatment in the latent stage they gain temporary 
immunity. Individuals may also be treated during the primary and secondary stages, although in this 
case they would not gain transient immunity, but instead become susceptible again. The rate of 
recovery from primary and secondary syphilis increased after the beginning of the intervention due 
to STI treatment as part of the services offered by NGOs. Syphilis treatment incorporates both 
syndromic management (whereby FSWs and high-risk MSM visiting Avahan clinics were examined 
and treated based on the presence of symptoms) and periodic presumptive treatment (PPT: 
treatment given at fixed intervals to FSWs/MSM at rates derived from district-level programmatic 
data given in Appendix Tables 7 and 11). These were modelled through an increased rate of recovery 
from both primary and secondary infection. PPT treatment was given at set intervals (every 3 
months prior to 2007; every 6 months after 2007) reflecting programmatic changes. Individuals 
receiving PPT were assumed to recover on average 1·5 months after infection prior to 2007, and 3 
months after 2007 due to this change in interval. In all FSW/MSM IBBAs, high proportions (2/3 or 
more) reported visiting an Avahan STI clinic in the 6 months (1 year for MSM) prior to the survey in 
round 1; it was thus assumed that all those who have symptoms will seek treatment. The time 
before seeking treatment after first developing symptoms was derived from IBBA survey data, based 
on self-reported delays. Since Avahan generally targeted MSM selling sex, it was assumed that only 
high-risk MSM received PPT or syndromic management of syphilis though Avahan clinics. 
Clients and low-risk MSM were assumed to only access non-Avahan services, and to only do so when 
symptomatic, with only a fraction developing symptoms. Since no data was available on the fraction 
of clients or low-risk MSM with primary or secondary syphilis who would seek effective treatment if 
they developed symptoms, the range for this parameter was assumed to be 0-100%, and the 
fraction of these men seeking treatment was thus the product of those developing symptoms and 
those would seek treatment when symptomatic. 
Condom use 
The efficacy of condoms in preventing infection was introduced at the per-act level when calculating 
the transmission hazard, and was specific to each STI19-22 as given in Appendix Table 2. 
Condom use among FSWs and clients 
Within the model, FSWs were stratified based on their level of condom use (“high”, “medium”, 
“low”). Condom use between FSWs and their clients (and for MSM visiting FSWs) was then 
determined by the level of the FSW within the model. These levels were based on the 4 categories of 
the IBBA surveys, with the middle two survey categories (“often” and “sometimes”) merged for 
simplicity as there was little difference in condom use with the last client between these two 
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categories from the IBBA surveys and the numbers in each group were relatively small. Increases in 
condom use over time were modelled by FSWs moving into higher condom use categories. 
In the model, each of the 3 categories was assigned a fraction of acts for which a condom was used, 
based on the proportion of that category reporting having used a condom with the last client. Thus 
FSWs in the “high” CCU category did not necessarily use condoms 100% of the time in their last act. 
The ranges for the proportion of FSWs using condoms with their last client, stratified by their CCU 
category, are given in Appendix Table 6. Note that the ranges for each category were not allowed to 
overlap with those from higher CCU categories, so that for example “low” condom users could not 
use condoms more frequently than “medium” condom users. However, it is likely that FSWs over-
report condom use due to social desirability bias. To account for this, based on comparison of data 
from FSWs and clients, and also using more anonymous polling booth surveys of FSWs, in each 
stratum of condom use, the proportion of acts in each stratum for which a condom was used was 
reduced by 0-25%23 from the value given in Appendix Table 6. 
Under the intervention condom hypothesis, condom use was assumed to increase linearly over time, 
from the value from the historical cohort reconstruction at the beginning of the intervention to the 
value measured in the FSW IBBA round 1, and then to the value in each subsequent FSW IBBA 
round. For the control condom hypothesis, condom use was assumed to increase linearly at the pre-
intervention rate until the last FSW IBBA round, although it was never allowed to exceed the level of 
the intervention hypothesis as it was assumed that Avahan did not decrease condom use. The trends 
in condom use under both hypotheses in each district are shown in Appendix Figure 1.  
After the last available FSW IBBA in each district (round 3 in Mysore, Belgaum, Bellary and round 2 in 
the other IBBA districts), condom use was taken to be constant due to the absence of any further 
data, and the potential for saturation of coverage. Both later rounds of the IBBA and the FSW polling 
booth surveys support this assumption that condom use has remained high and constant since the 
most recent round of the IBBA. 
The fraction of medium CCU FSWs was found to be low in the IBBA; it was taken to increase linearly 
to the IBBA round 2 value (and thence change linearly to the R3 value in Mysore, Belgaum and 
Bellary). Constraints were introduced when sampling to ensure that proportions of FSWs in the 
“high”, “medium”, and “low” CCU groups summed to one. Condom use reported in the IBBA for 
regular and occasional clients was similar, and thus condom use with regular clients was assumed to 
be the same for simplicity. 
Condom use between MSM 
Since the population of high-risk MSM was in general substantially smaller than that of FSWs, MSM 
were not stratified by their level of condom use. In each district, there were two levels of average 
condom use among MSM for short-term (typically commercial) MSM partnerships and for regular 
MSM partnerships. The latter was assumed to be proportional to the former at all times and related 
by a district-specific factor given in Appendix Table 11. This factor was derived from IBBA survey data 
based on the district-level ratio of condom use at last act with the regular MSM partner compared to 
the last act with a paying or non-regular partner. Condom use was assumed to be the same for high 
and low-risk MSM. 
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Average condom use for MSM with short-term MSM partners at the start of the intervention was 
derived using the historical cohort method, and prior to Avahan it was assumed to change linearly at 
the rate obtained from the historical cohort. Under the intervention condom hypothesis, from the 
start of Avahan it was assumed to increase linearly from the value at the beginning of the 
intervention to the value measured in the MSM IBBA round 1. In Mysore, Belgaum, Bellary and 
Shimoga there was no second MSM IBBA round, and so condom use remained constant after this 
time, while in all other districts it increased to the value in the second MSM IBBA round, remaining 
constant thereafter. Under the control condom hypothesis it increased at the pre-intervention rate 
until the last MSM IBBA round. Again, condom use under the control condom hypothesis was never 
allowed to exceed that under the intervention condom hypothesis. 
Other time-varying parameters 
In addition to condom use, the number of occasional and regular clients of FSW was also allowed to 
change over time within the model. The total number of clients per FSW at each round of the IBBA is 
shown in Appendix Table 8. Within the model, the number of clients was assumed to be at the round 
1 value initially, before changing linearly between values from one round to the next, and then 
remaining at the value of the final round in the absence of any further data. 
The number of regular clients at round 1 is also shown in Appendix Table 8. This was used to derive 
the fraction of clients who were regular at round 1, and it was assumed that this fraction remained 
constant over time, with the number of occasional and regular clients each varying within the model 
to give the total number of clients at each time. 
 
General population model component 
Transmission of HIV and HSV-2 to the general population was modelled by an individual-based 
component coded in the Python programming language. The general population model component 
captures the downstream transmission of HIV and HSV-2 to partners of individuals who engage in 
risky behaviour (clients and MSM), as well as those who have ceased risky behaviour, for the 
parameter sets whose runs had passed the target-fitting stage (the posterior parameter set). In order 
to capture stochastic effects, the general population model component was run 5 times for each 
model fit from in the posterior parameter set, and then using the mean value as the output from the 
general population model component. Ranges for the behavioural parameters used in this model 
component are in Appendix Tables 9 and 10, while the biological parameters used were the same as 
for the high-risk model component. 
The model tracks current clients and MSM, and any HIV positive former clients or MSM, as well as 
the long-term female partners of any of these individuals. It also includes HIV positive women who 
were FSWs previously and general population women who are HIV positive who were infected by a 
partner engaging in high-risk activity who subsequently died. It is assumed that once a person ceases 
high-risk activity, that they are no longer at risk of infection with HIV. 
Some FSWs reported having long-term non-commercial partners. These partners were assumed, as 
described before, to be themselves clients in the absence of data on their identity, since their level of 
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risk of HIV infection would be high, and these partnerships were included in the high-risk model 
component. The number of such partnerships was therefore subtracted from the number of client 
non-commercial long-term partnerships, with only the remaining partnerships being modelled in the 
general population model component. 
For simplicity, since syphilis prevalence was low in clients and MSM, and thus the resulting average 
cofactor from syphilis was small, syphilis was not included in the low-risk model component. A 
further simplification was introduced by only having susceptible and infected categories for HSV-2, 
with the HSV-2 transmission probability and cofactors for HIV increased to account for higher 
transmission/cofactors during symptomatic HSV-2 by weighting the effect by the relative time per 
year spent in each stage. Condom use at last act reported in the GPS and GPS PBS surveys was low, 
and was assumed to remain constant throughout the simulation. 
Events were modelled using a time-step of one month, using discrete time-steps so that this 
component could be synchronised with the output from the high-risk model component. The steps in 
the general population model component were then divided into two parts. In the first, output from 
the high-risk model component was used to update the numbers and disease stages of clients and 
MSM, and the number of ex-FSWs, as follows: 
1. Update number of HIV positive ex-FSWs, by adding the number of women ceasing selling sex 
who are HIV positive. 
2. Add new clients/MSM. 
3. Move clients to later duration classes. 
4. Allow some clients to cease buying sex. Those who are HIV positive remain in the model as 
HIV positive ex-high risk men. 
5. Allow some MSM to cease MSM activity. Those who are HIV positive remain in the model as 
HIV positive ex-high risk men. 
6. Some clients/MSM die from AIDS and non-AIDS related causes. If their partners have been 
infected with HIV, then their disease progression is modelled. 
7. Some clients/MSM become infected with HIV. 
8. Some clients/MSM become infected with HSV-2. 
9. HIV+ clients/MSM may progress to a later stage of HIV. 
The second step in the general population model was to update the numbers and disease stages of 
the partners, as well as the progression of HIV in HIV positive former high-risk individuals: 
1. Some clients/MSM may get long-term female partners. For clients this rate depends on their 
duration class to ensure that the fraction of married clients by duration as client matches 
the values from client IBBA survey data. 
2. Female partners of HIV positive clients, MSM or ex-high risk men may get infected with HIV, 
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at a rate depending on the HIV stage of infection of the man, as well as the HSV-2 infection 
status of both partners. 
3. Female partners of HSV-2 positive clients, MSM or ex-high risk men may get infected with 
HSV-2, at a rate depending on the HIV infection status of the man. 
4. Update the HIV disease progression of HIV positive ex-FSWs and ex-high risk men, and all 
female partners. 
5. Some HIV positive ex-FSWs, ex-high risk men, and female partners may die from either AIDS 
or non-AIDS related causes. 
The general population model was run over the same time period as the high-risk model 
component, ending in 2015. There was no difference in behaviour between the intervention condom 
hypothesis and the control condom hypothesis in the general population model component, and 
thus the impact in the general population was solely due to the reduced number of HIV positive men 
from the high-risk model component under the intervention condom hypothesis. 
Impact analysis 
We estimated infections averted among FSWs, clients of FSWs, MSM, and long-term non-
commercial partners of clients and MSM. To account fully for all sources of uncertainty, we derived 
five alternative overall impact estimates across all Avahan districts with increasing uncertainty, 
reflecting the hypothesis-testing results and that not all IBBA districts had surveys amongst MSM 
and the general population.  
Our first overall impact estimate of HIV infections averted only included the IBBA districts where 
there was medium or strong evidence for the intervention condom hypothesis (i.e. Bayes factor>2), 
and we estimated infections averted among MSM and the general population only for districts with 
IBBA/GPS data available for these populations. This produced the most conservative impact 
projections with the lowest level of uncertainty. With increasing uncertainty, we then successively 
extrapolated our impact projections. 
The second impact estimate used the relative reduction in overall impact resulting from excluding 
MSM from the model for districts which had MSM IBBAs to estimate the infections averted among 
MSM in districts without MSM data. Third, the intervention impact in the general population for 
districts without GPS was derived using client IBBA surveys where available, or else client data from 
other districts, to parameterise partnership duration and condom use in the general population 
model component. Fourth, we produced estimates of infections averted for all modelled districts, 
including those that had weak evidence for the intervention condom hypothesis (Bayes factor≤2). In 
this case, it was assumed that there was an increase in condom use due to the intervention even 
when the evidence for this was not strong. Finally, because IBBAs were only conducted in about one-
third of all Avahan districts, we extrapolated our estimates of infections averted to all non-IBBA 
districts.  
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This final extrapolation was done using separate linear regression models for the overall number of 
HIV infections averted over four and ten years of Avahan, producing overall impact estimates of 
Avahan in South India, but with the highest level of uncertainty. Only data quantities available across 
all Avahan districts were included as possible explanatory variables in the regression models, 
including sizes of high-risk populations, coverage and intensity indicators from programme data, and 
a variable describing whether Avahan was the main FSW HIV intervention in that district in 2004-5. A 
full list of variables is given in the Appendix. Variables associated with the model projections of the 
number of HIV infections averted over four and ten years in IBBA districts in univariate analysis at p-
values <0·1 were then used to develop multivariable linear regression models. The models were 
each built step-wise, incorporating the variable explaining the most residual variance at each step, 
until the likelihood ratio test suggested that additional variables no longer improved the model (p-
value<0·05), and these regression models were then used to estimate the number of HIV infections 
averted over four and ten years in all non-IBBA districts. The method used to generate uncertainty 
bounds is described in the Appendix. The statistical analysis was conducted using STATA SE version 
11.2.3  
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Supplementary material C - Detailed fitting procedure and likelihood 
weights 
 
The fitting process, used on each parameter set generated by Latin hypercube sampling, consisted of 
several steps described in detail below, which were carried out for each of the intervention and 
control condom hypotheses. Firstly each parameter set was pre-screened to reduce the 
computational time spent on parameter sets which would produce highly unrealistic prevalences. 
Then the model was run with HIV until 1987 to ensure that the HIV epidemic at that point was not 
totally inconsistent with the observed epidemiological prevalence data from India at that time, 
which represented the first measurements of HIV in the country. Finally runs which fulfilled both 
these conditions were run to 2015, and checked to see if they fitted the epidemiological prevalence 
data for all risk groups in that district from the IBBA data. 
Latin hypercube sampling 
Latin hypercube sampling is a technique frequently used for sampling parameter spaces in 
epidemiology to ensure that all regions of the parameter space are sampled equally. In Latin 
hypercube sampling, the range of each parameter is divided into k equiprobable intervals, and k 
parameter sets are formed so that each one of these intervals is sampled once. Parameter sets are 
formed by taking one element from each parameter sample without replacement, thus forming k 
parameter sets overall. A value of k=1000 was taken, although smaller and larger k were found not 
to alter results. 
Pre-screening 
Pre-screening involved running the high-risk component of the model for syphilis and HSV-2, but 
without HIV, and with condom use set to be constant at the last FSW IBBA round value, until the 
prevalences reached equilibrium so as to simulate the level of these STIs in the absence of HIV. Runs 
which had FSW HSV-2/syphilis prevalence so far from the FSW IBBA R2 levels that they would still 
not fit the prevalence data even in the presence of HIV were thus screened out (the condition for 
screening out syphilis, >44% syphilis prevalence in FSWs, was a loose upper bound based on the 
highest prevalence of TPHA-positive FSWs, representing ever-infected with syphilis, across all 
districts; the condition for HSV-2 was that prevalence in FSWs was above 1%).  
High-risk model component initial conditions and consistency check in 1987 
If the parameter set passed this initial pre-screening, the system was then re-set with condom use as 
determined by the scenario under investigation with an initial FSW HIV prevalence of 0·5% seeded 
proportionately across all FSW behavioural classes, and with HSV-2 and syphilis at their pre-HIV 
equilibrium values, as initial conditions.  
The start of the epidemic was itself a sampled parameter, and the high-risk model component was 
run from that time until 1987 when systematic HIV measurement began in India.24 At this point a 
further screening was carried out to determine if the parameter set was likely to produce a realistic 
epidemic or not. Based on the earliest published HIV prevalence data from India,25 an approximate 
upper bound for FSW HIV prevalence of 16% was set. Parameter sets which passed this second 
screening step were then run until 2015. 
16 
 
 
In Chitoor, and districts in Tamil Nadu state, observed HIV prevalence was low, while derived FSW 
CCU trends suggested that condom use was low in the past. Therefore in these districts, while the 
pre-screening phase for HSV-2 and syphilis was carried out as before, the model was started 
between 1995-2003, with FSW HIV prevalence set to 0·5%. There was no fitting condition in 1987 for 
these districts as this was before the start of the simulation. However, in these districts, fitting to 
IBBA data was carried out as for all other districts. 
Target-fitting 
Parameter sets which passed the pre-screening and the consistency check in 1987 were next tested 
to see if the corresponding model estimates lay within the 95% confidence interval (CI) of the FSW 
round 1 IBBA HIV prevalence data, as well as all rounds of client or MSM IBBA HIV prevalence data in 
districts where available. They were also required to fit the trend from round 1 to round 2 (and 
round 1 to round 3 in districts with a third round) of HIV prevalence in FSWs, calculated as the 
prevalence ratio after adjusting for changes in key variables such as FSW typology and localite status. 
Appendix Table 14 lists the variables adjusted for in each district as well as the corresponding 
adjusted prevalence ratio. Finally, the model prevalence estimates were required to lie within 3CI of 
the FSW round 1 HSV-2 and high-titre syphilis prevalence data.  
The parameter sets that provided adequate fits as described above under the intervention condom 
hypothesis formed the posterior parameter distribution, and this was used to estimate impact. 
Based on experimentation comparing statistics from smaller and larger numbers of fits, using 50 
fitted runs was found to be more than adequate, although since batches of runs were carried out 
there were often many more fits for a given district. In only one district was less than 50 runs 
obtained (Hyderabad) although in this district impact was exceptionally low and the absolute 
uncertainty in impact estimates was small. 
In Chennai the round 2 client HIV prevalence was not used in fitting as it was substantially higher 
(8·5%) than both the round 1 value (2·0%) and the FSW HIV prevalence (2·2% in round 1; 2·4% in 
round 2). 
In two of the 24 IBBA districts, there were inconsistent prevalence trends between risk groups, with 
some increasing and others decreasing disproportionately over successive IBBA rounds. This was 
confirmed by modelling, suggesting that there were problems with the sampling frame of one or 
more surveys in these districts. As it was impossible to determine which surveys were not valid, 
these districts were not modelled but as there was no element of selection in this, we do not 
anticipate that it would affect the results. 
Bayes factor and hypothesis-testing 
In order to see which condom use hypothesis was more likely (H0: the “control condom hypothesis” 
that CCU increased at the same rate during Avahan as beforehand; or H1: the “intervention condom 
hypothesis”, that condom use did increase during Avahan following the estimated historical CCU 
trends), a Bayesian model comparison method was used, using the Bayes factor to determine which 
model was more consistent with data.26 Similar methods have been used before8,27,28 in modelling 
HIV epidemics in India and other settings.  
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The Bayes factor measures the average ability of the model to reproduce the observed HIV/STI 
prevalence data, and it is defined as: 
  
∫                  
∫                   
 
  represents the set of model input parameters,      is the associated prior distribution, and 
           is the marginal likelihood of model x given the data D.  
For a large enough sample, the ratio 
                                                
                                           
 
would converge to K. However, in practice convergence was observed empirically by comparing the 
ratios observed with two different Latin hypercube samples for a given district, which were found to 
be extremely similar. This test was repeated for all modelled districts by continuing to sample 
parameter sets until the ratio for that district was approximately constant. 
Based on the convention of references 26 and 29, a value of     >2 gives moderate evidence that 
condom use increased following the intervention hypothesis, and     >5 gives strong evidence of 
this. 
Likelihood weights and associated statistics 
For each fitted run, a corresponding likelihood weight was generated using the method described 
fully in 14, based on the likelihood of the IBBA data given the model estimate of HIV/HSV-2/syphilis 
prevalence in each risk group in each round. The IBBA data used in generating the likelihood weights 
are given in Appendix Tables 15 and 16. 
The median and percentile prevalences and other model outcomes using these weights were 
calculating by ordering each outcome by size, and choosing the run where the cumulative likelihood 
weight equalled or exceeded the relevant percentile level. 
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Supplementary material D: Additional results 
 
Determinants of the proportion of HIV infections averted 
Appendix Figures 2a and 2b show scatterplots of the overall proportion of HIV infections averted 
over 4 years in each district against (a) the total increase in FSW CCU, and (b) the pre-intervention 
FSW CCU level. These two variables were strongly negatively correlated (correlation coefficient 
−0·93), and both were strongly associated (p<0·001 in both cases) with overall proportion of HIV 
infections averted. The pre-intervention FSW CCU level explained 70% of variability.  
Extrapolation of impact to non-IBBA districts 
Two univariate regression analyses were carried out using STATA, version 11.0.3 The dependent 
variables for the two analyses were the number of HIV infections averted over 4 years and to 2013 
from all risk groups. From scatter plots as well as more formal tests, Madurai was found to be an 
outlier for the analysis of the number of HIV infections averted over 4 years, and Madurai and 
Chitoor were both outliers for the number of HIV infections averted up to 2013. Madurai was 
therefore excluded from both analyses, while Chitoor was excluded from the second analysis only. 
Appendix Table 17 shows the independent variables used, and the results of each of the univariate 
regression analyses. 
Multivariable linear regression models were then built with the number of HIV infections averted 
over each time period as the dependent variables. The total number of FSWs was included a priori in 
both models, as this was known to be a key determinant of the size of the overall number of HIV 
infections averted. All other independent variables with a p-value <0·1 were then possible inclusions 
in each model. Independent variables were added sequentially to each model incorporating the 
variable explaining the highest residual variance at each step, until the likelihood ratio test 
suggested that adding further variables did not significantly improve the model. There was a high 
degree of correlation (correlation coefficient 0·72) between the overall number of FSWs and the 
number of street-based FSWs, and the latter variable was not surprisingly excluded from the final 
model. Appendix Table 18 gives the final model coefficients and associated p-values. 
Credibility intervals for extrapolated impact 
In order to generate 95% credibility intervals for the overall number of HIV infections averted across 
all 69 Avahan districts, the variability from both the extrapolation between districts and from within 
each modelled IBBA district had to be taken into account. To do this, a Latin hypercube sample (LHS) 
(N=10000) of overall impact from each of the modelled IBBA districts was generated. For each 
district, the likelihood weights were used as the probability of each run being picked.  
Next, for each sample i of these (i=1..N), a multivariable linear regression was carried out using the 
independent variables already described (number of FSWs, whether the district was in Maharashtra, 
whether Avahan, and the impact in all the non-modelled districts was estimated including the 
corresponding 95% CI. This impact was then summed over all districts, with the contribution from 
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the modelled IBBA districts included, to generate an estimate of the overall impact across the 69 
districts for each sample i. Finally the 2.5 percentile of the lower limit of the i samples, and the 97.5 
percentile of the upper limit, were calculated.  
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Supplementary material E: Additional tables 
 
District Intervention start  
IBBA survey dates 
State FSW R1 FSW R2 FSW R3 Client R1 Client R2 MSM R1 MSM R2 
Andhra 
Pradesh 
Chitoor    May 2004 June 2006 Sept 2009 NA NA NA NA NA 
East Godavari Apr 2005 Mar 2006 Mar 2009 NA Oct 2006 Apr 2009 Apr 2006 Apr 2009 
Guntur     Aug 2004 May 2006 June 2009 NA Nov 2006 July 2009 May 2006 July 2009 
Hyderabad  May 2004 Feb 2006 June 2009 NA Nov 2006 July 2009 June 2006 June 2009 
Karimnagar Dec 2004 Nov 2005 Aug 2009 NA NA NA NA NA 
Prakasam   Jan 2005 May 2006 May 2009 NA NA NA NA NA 
Vizag      Sept 2004 May 2006 Mar 2009 NA Oct 2006 Apr 2009 May 2006 Apr 2009 
Warangal   May 2004 Feb 2006 July 2009 NA Sept 2006 Aug 2009 — — 
Karnataka Bangalore  Jul 2005 July 2006 Jan 2009 NA Sept 2007 NA July 2006 Dec 2009 
Belgaum    Apr 2004 Oct 2005 July 2008 Sept 2010 Oct 2007 NA July 2008 NA 
Bellary    Jul 2004 Nov 2005 Aug 2008 Oct 2010 Oct 2007 NA Aug 2008 NA 
Mysore     Jan 2004 Aug 2004 Dec 2006 Mar 2009 Oct 2008 NA July 2008 NA 
Shimoga    Jul 2004 Aug 2005 Sept 2008 NA Nov 2007 NA July 2008 NA 
Maharashtra Kolhapur   Mar 2006 Mar 2006 July 2009 NA NA NA NA NA 
Mumbai Dec 2004 Apr 2006 Nov 2009 NA Feb 2007 Jan 2010 Jan 2007 Dec 2009 
Parbhani   Feb 2005 Nov 2006 Oct 2009 NA Nov 2006 Nov 2009 NA NA 
Pune Dec 2004 June 2006 Aug 2009 NA Feb 2007 Jan 2010 Oct 2006 Jan 2010 
Thane Dec 2004 Apr 2006 June 2009 NA NA NA NA NA 
Yevatmal   Feb 2005 Apr 2006 Sept 2009 NA Nov 2006 Oct 2009 NA NA 
Tamil Nadu Chennai    Oct 2004 July 2006 July 2009 NA Dec 2006 Aug 2009 July 2006 Aug 2009 
Coimbatore Oct 2004 June 2006 Aug 2009 NA NA NA June 2006 Aug 2009 
Dharmapuri Oct 2004 Apr 2006 Mar 2009 NA NA NA NA NA 
Madurai    Oct 2004 Mar 2006 Mar 2009 NA Oct 2006 Aug 2009 Mar 2006 Mar 2009 
Salem      Oct 2004 Mar 2006 Mar 2009 NA Sept 2006 June 2009 Mar 2006 Mar 2009 
Table 1: Start date of Avahan intervention and dates of all IBBA surveys for each district. NA = no survey round for that risk group in the given district. 
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Definition of model input Model inputs Reference  
HIV model parameters   
Average duration of HIV stages (months):  Based on 
30,31
. 
 Initial HIV high viraemia phase  2-6 
 Between initial high viraemia and pre-AIDS 70-91 
 Pre-AIDS high viraemia phase 6-18 
Probability of HIV transmission per sex act in asymptomatic stage:   
 Male-to-female 0·06-0·11% Reviewed in 
32
 
 Female-to-male 0·01-0·14% 
 From receptive anal intercourse (AI) 0·2-2·5% Reviewed in 
33
 
 RR for receptive AI compared to uncircumcised insertive AI 2-7 From 
33,34
 
 From insertive AI when circumcised 0·11% From 
34
 
HIV transmission multiplicative RR per sex act:   
 Initial/pre-AIDS high viraemia phases 4·5-18·8/4·5-11·9 From 
32,35,36
 
HSV-2 model parameters   
Average duration of HSV-2 stages (months):   
 Primary stage 0·36-0·66 From 
37-42
  
 Symptomatic recurrence 0·10-0·16 Using 
37,42-46
 
 Rate of HSV-2 symptom recurrences per month while:  HIV -ve 0·09-0·41 Using 
41-43,47-49
 
                                                                                                                   HIV +ve 1·5-2*HIV negative rate From 
15,16
 
Probability of HSV-2 transmission per sex act:   
 Latent/asymptomatic shedding stage (male to female) 0·05-0·20% 
22,50
 
 Ratio male-to-female: female-to-male transmission 2-5 
 Between MSM 0·07-0·16% Based on 
51
 
HSV-2 transmission multiplicative RR per sex act:   
 Primary HSV-2 infection 2-6*6·7-25 
22,49,50
 
 Symptomatic recurrence stage 1-3*6·7-25  
49,52
 
Syphilis model parameters   
Average duration of syphilis stages (months):  Available data was 
reviewed by 
18
  Primary (no treatment) 1·5 
 Secondary (no treatment) 3·0-4·5 
 Primary and secondary stage (with background treatment) 1-5 
 Latent phase (including treatment) 2-24 
 Time between recurrences in latent period 6 
 Immune/resistant phase 12-60 
Probability of male-to-female syphilis transmission per sex act 0·03-0·2 Based on 
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Ratio of syphilis transmission probabilities female to male: male to female 0·33-1·0 
Effectiveness of PPT in treating primary/secondary syphilis 70-100% 
53,54
 
Cofactors   
HSV-2 cofactor per sex act for increasing HIV infectivity:  Using 
55-67
 and 
68
 to 
convert from 
differences in HIV 
viral load. 
 Primary and symptomatic recurrence phases 1·27-2·57*1-2 
 Asymptomatic/latent phase 0·27-1·57* 0·04-0·15*2-3 
HSV-2 cofactor per sex act for increasing HIV susceptibility:  
 Asymptomatic/latent phase 1-4·75 
 Primary phase and symptomatic recurrence phase 1·5-4·0 
Average primary and secondary stage syphilis cofactor per sex act for 
increasing susceptibility to HIV  
2·1-3·3 Using 
69
 
HIV cofactor per partnership for increasing HSV-2 infectivity:  Using 
64,70-72
 and 
converting to 
probability with 
68
 
 Primary/symptomatic recurrence phases 1-2·5 
 Asymptomatic/latent phase 2-4 
Condom parameters   
Per-act condom effectiveness against:   
 HIV/HSV-2 and syphilis 0·8-0·95/0·4-0·7 
20,21
/
19,22
  
Table 2: Ranges for biological parameters used in model
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Definition of model input Model inputs Reference  
STI treatment parameters   
Percentage of FSWs who get effective non-Avahan treatment for syphilis 9·8-27·8% Survey data 
Percentage of high-risk MSM who get effective non-Avahan treatment for 
syphilis 
8·1-26·7% Survey data 
Percentage of symptomatic clients and lower-risk MSM with 
primary/secondary syphilis who seek effective non-Avahan treatment 
0-100% Assumption 
Percentage of clients and low-risk MSM who develop symptoms from 
syphilis 
21-45% Survey data and 
73
 
Non-district-specific behavioural parameters   
Number of sex acts with each occasional client 1·1-1·5 Survey data 
Number of sex acts per year with each regular client 42-55 Survey data 
Duration of partnership with regular clients (years) 3·2-7·2 Survey data 
Number of acts per year between regular MSM partners 155-222 Survey data 
Proportion of all high-risk MSM receptive AI partnerships which are with 
other high-risk MSM 
0-20% Survey data 
Proportion of all lower-risk MSM insertive AI partnerships which are with 
other lower-risk MSM 
0-20% Survey data 
Fraction of over-reporting of condom use due to social desirability bias 1-1·34 
74
 
Start date of HIV epidemic 1995-2003 (in Chitoor 
and Tamil Nadu) 
1976-1985  (all other 
districts) 
Assumption 
Table 3: Non-district-specific behavioural parameters ranges used in model 
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District Number of FSW 
Number of 
high-risk MSM 
Number of 
low-risk MSM 
Annual per capita growth 
rate of general 
population 
Per-capita rate of leaving due to non-HIV death 
or migration (years-1) 
Men Women 
Chitoor    4910-7360 NA NA 1·36% 0·022 0·022 
East Godavari 1040-1560 1220-1830 3610-9450 0·71% 0·026 0·025 
Guntur     4770-7160 1730-2600 4040-10600 0·70% 0·026 0·025 
Hyderabad  620-930 1820-2730 1820-32800 1·59% 0·021 0·021 
Karimnagar 2010-3020 NA NA 1·35% 0·022 0·022 
Prakasam   2340-3510 NA NA 1·02% 0·024 0·024 
Vizag      930-1400 883-1320 4900-12800 1·43% 0·022 0·022 
Warangal   1380-2070 NA NA 1·37% 0·022 0·022 
Bangalore  8010-12000 4290-6430 20400-53400 2·99% 0·015 0·015 
Belgaum    1440-2170 1270-1910 3040-7960 1·60% 0·021 0·021 
Bellary    2850-4270 360-540 5890-15400 2·01% 0·019 0·019 
Mysore     1590-2380 810-1210 3160-8260 1·40% 0·022 0·022 
Shimoga    1350-2020 220-330 1850-4830 1·21% 0·023 0·023 
Kolhapur   570-850 NA NA 1·62% 0·021 0·021 
Mumbai 8090-12100 1660-2480 13000-34000 0·47% 0·027 0·027 
Parbhani   1130-1700 NA NA 1·42% 0·022 0·022 
Pune 3630-5440 2210-3320 13700-35700 2·67% 0·016 0·016 
Thane 6100-9150 NA NA 4·37% 0·010 0·010 
Yevatmal   700-1060 NA NA 1·69% 0·021 0·021 
Chennai    3020-4530 3020-4530 14700-38400 0·93% 0·024 0·024 
Coimbatore 1420-2140 1420-2140 9700-25400 1·86% 0·020 0·020 
Dharmapuri 1960-2940 NA NA 1·54% 0·022 0·021 
Madurai    5980-8970 1220-1840 4710-12300 0·65% 0·026 0·026 
Salem      2370-3550 1370-2050 4650-12200 1·50% 0·022 0·022 
Table 4: Ranges for prior distribution of demographic model parameters. Ranges are based on size mapping estimates and 2001 India district-level census data. NA = not applicable, since no MSM IBBA 
survey was carried out in this district; the number of MSM was set to zero in these districts, and impact in MSM was then estimated subsequently according to the strength of estimate of the total Avahan 
impact estimate.  
 
24 
 
 
District 
Proportion of 
FSW who are 
lower activity 
Average time spent in sex work Non-commercial partnerships 
Lower activity Higher activity 
% of FSWs 
having partner 
Duration Number of sex 
acts per month 
Chitoor    0·50-0·62 46·3-58·0 58·3-75·3 82·2-90·1 212·0-250·0 10·7-13·8 
East Godavari 0·44-0·63 98·4-127·0 72·9-93·6 72·3-83·9 192·0-264·0 11·7-13·9 
Guntur     0·48-0·63 64·2-80·6 65·4-84·7 79·4-89·1 226·0-275·0 11·3-13·5 
Hyderabad  0·48-0·65 42·4-53·3 55·8-71·9 84·5-92·9 283·0-346·0 9·6-11·4 
Karimnagar 0·44-0·59 62·4-78·6 64·9-78·6 67·2-79·6 171·0-233·0 12·3-15·4 
Prakasam   0·49-0·64 50·7-63·3 52·3-67·4 84·7-91·7 212·0-254·0 11·6-14·2 
Vizag      0·46-0·60 82·1-104·0 55·5-70·9 80·0-89·6 204·0-261·0 11·3-14·2 
Warangal   0·41-0·60 86·2-111·0 86·0-110·0 68·8-85·4 252·0-299·0 10·3-12·4 
Bangalore  0·47-0·58 37·4-44·9 37·6-45·6 41·9-54·3 191·0-231·0 7·8-9·8 
Belgaum    0·47-0·62 149·0-202·0 99·4-131·0 21·5-31·3 200·0-260·0 6·2-8·9 
Bellary    0·44-0·60 105·0-136·0 86·0-111·0 25·1-38·2 180·0-231·0 7·3-9·3 
Mysore     0·50-0·60 37·8-47·4 52·1-67·1 39·3-48·8 103·0-157·0 5·9-8·8 
Shimoga    0·52-0·65 50·6-63·3 62·0-81·1 43·4-53·9 169·0-219·0 6·8-8·6 
Kolhapur   0·34-0·69 68·1-111·0 37·3-59·5 64·1-83·7 112·0-225·0 7·8-13·4 
Mumbai 0·45-0·70 66·3-87·4 52·1-71·1 40·2-55·4 145·0-206·0 8·9-12·2 
Parbhani   0·34-0·73 69·3-89·0 78·6-103·0 65·2-97·7 108·0-236·0 3·8-13·6 
Pune 0·50-0·65 88·1-115·0 69·4-92·9 61·5-74·5 142·0-227·0 5·3-10·1 
Thane 0·45-0·58 41·4-52·7 29·3-37·9 57·7-70·3 129·0-193·0 9·1-11·7 
Yevatmal   0·43-0·63 41·3-60·9 35·5-54·2 71·0-82·0 72·7-135·0 8·8-18·3 
Chennai    0·54-0·65 47·8-59·4 47·9-62·2 70·3-82·6 248·0-303·0 7·0-9·0 
Coimbatore 0·58-0·70 50·3-62·2 44·2-58·2 78·3-89·0 194·0-233·0 11·7-14·2 
Dharmapuri 0·48-0·60 61·6-77·6 58·2-74·6 65·5-81·3 136·0-176·0 12·6-15·5 
Madurai    0·51-0·66 57·1-71·6 78·8-103·0 82·9-94·2 228·0-310·0 9·5-12·2 
Salem      0·48-0·66 43·7-55·0 45·6-59·0 79·7-89·4 174·0-248·0 7·2-9·6 
Table 5: FSW parameters used in model. All durations are in months. 
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District 
Annual % 
increase in 
CCU before 
Avahan 
% of FSW in the  high CCU group % of FSWs in R2 who 
are in the CCU group 
% of acts for which a condom is used 
among those in CCU group 
At the start 
of Avahan 
At IBBA 
round 1 
At IBBA 
R2 
At IBBA 
R3 Medium Low High Medium Low 
Chitoor 0·16-1·73 1·0-12·2 30·2-42·1 78·2-90·4 NA 9·6-21·8 0 98·7-100 72·7-84·5 0·0-36·8 
East Godavari 4·14-6·77 23·2-36·6 76·2-87·8 95·3-99·1 NA 0·2-3·7 0·0-1·7 94·6-99·3 59·0-91·8 0 
Guntur 0·89-2·21 5·6-14·6 81·9-91·3 75·5-90·2 NA 9·5-24·3 0·0-0·5 98·9-100 60·8-89·1 0·0-67·9 
Hyderabad 4·04-12·3 25·9-53·1 47·2-64·0 61·1-78·9 NA 18·9-36·8 0·1-4·3 96·0-100 90·5-96·0 0 
Karimnagar 0·63-4·14 3·2-13·4 66·8-80·1 69·1-81·0 NA 16·7-27·7 1·1-4·5 95·9-100 72·2-91·2 0 
Prakasam 0·18-0·99 1·2-7·0 35·0-44·9 92·6-98·6 NA 0·0-1·6 0·9-6·3 98·4-100 63·7-76·9 0 
Vizag 1·46-2·99 10·1-20·3 85·4-92·9 80·2-90·0 NA 10·0-19·8 0 95·5-99·2 52·8-85·5 0 
Warangal 0·54-6·44 1·27-23·1 80·2-91·1 68·2-84·1 NA 15·2-30·4 0·0-2·6 96·4-99·5 54·5-92·4 0 
Bangalore 0·0-4·36 39·3-54·2 73·9-82·1 82·6-88·9 NA 9·1-15·1 1·0-3·4 90·7-96·9 56·0-74·4 1·8-31·8 
Belgaum 3·27-5·67 42·2-54·7 87·2-94·5 85·6-92·6 94·6-98·7 7·4-14·4 0 91·9-97·3 33·9-84·1 0·0-33·9 
Bellary 3·90-6·54 29·7-47·9 66·8-78·7 85·4-92·8 82·9-91·9 6·1-12·7 0·1-2·9 90·8-97·0 43·8-76·5 33·5-43·8 
Mysore 1·63-3·77 13·0-23·6 30·7-40·2 61·5-72·9 88·3-94·1 24·5-36·6 0·4-4·2 81·7-92·8 54·2-67·0 7·0-38·2 
Shimoga 2·68-5·96 21·1-38·7 48·8-61·8 78·9-88·7 NA 7·4-16·6 2·0-6·3 83·2-93·6 53·4-74·2 18·3-46·4 
Kolhapur 1·01-8·14 68·7-91·8 86·9-100 98·5-100 NA 0·0-1·6 0 87·8-98·2 0·0-87·8 0 
Mumbai 2·88-6·60 63·7-80·8 68·8-90·7 82·8-89·5 NA 10·1-16·7 0 93·6-100 82·6-93·6 0·0-49·6 
Parbhani 1·31-9·86 34·2-77·8 88·8-91·0 96·6-99·7 NA 0·3-3·5 0 100 13·7-100 1·6-9·5 
Pune 8·24-13·5 80·1-91·7 89·9-96·1 94·1-98·8 NA 0·8-5·5 0 96·5-99·7 96·2-96·5 0 
Thane 8·94-15·0 81·6-94·6 95·6-100 77·1-96·3 NA 3·5-22·8 0 96·2-100 74·3-96·2 0 
Yevatmal 9·58-13·7 41·6-68·7 93·7-100 97·1-100 NA 0 0·0-2·9 100 0·0-100 0 
Chennai 3·53-7·33 21·7-40·6 86·9-95·3 91·2-97·7 NA 2·0-8·5 0·0-0·6 97·5-100 56·3-96·9 0 
Coimbatore 0·0-1·11 0·8-7·0 35·0-46·8 93·7-98·1 NA 1·9-6·3 0 95·0-100 87·7-95·0 0 
Dharmapuri 0·59-2·18 5·8-13·7 63·4-74·2 66·9-80·6 NA 14·5-27·3 1·1-9·6 93·6-99·1 92·1-93·6 0 
Madurai 1·31-4·71 11·1-24·9 64·8-77·2 99·7-100 NA 0·0-0·3 0·0-0·2 98·3-100 41·8-72·7 0 
Salem 0·55-4·12 11·1-28·5 72·8-84·8 91·6-97·8 NA 1·9-7·9 0·0-1·2 96·5-100 63·4-96·0 0 
Table 6: Ranges for parameters for FSW condom use with occasional clients.  
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District 
Number of FSWs on 
PPT before Jan 2007 
Number of FSWs on PPT 
after Jan 2007 
Average time for FSW to get Avahan 
treatment for syphilis (months) 
Chitoor 120-330 590-1170 0·36-0·48 
East Godavari 120-260 350-610 0·29-0·47 
Guntur 1020-1160 280-1310 0·49-0·57 
Hyderabad 60-90 60-170 0·28-0·43 
Karimnagar 60-100 210-590 0·47-0·64 
Prakasam 530-580 520-860 0·33-0·45 
Vizag 220-300 0-140 0·41-0·53 
Warangal 40-110 300-1180 0·31-0·42 
Bangalore 280-810 1000-1660 0·36-0·54 
Belgaum 280-430 600-650 0·46-0·71 
Bellary 980-1500 120-1020 0·58-0·81 
Mysore 130-180 430-630 0·26-0·40 
Shimoga 80-160 10-90 0·40-0·65 
Kolhapur 50-80 130-170 0·12-0·36 
Mumbai 760-2190 610-620 0·24-0·70 
Parbhani 40-100 190-490 0·11-0·45 
Pune 130-170 560-1290 0·16-0·34 
Thane 1400-4480 1400-4480 0·31-0·56 
Yevatmal 30-80 80-210 0·11-0·26 
Chennai 150-280 530-630 0·09-0·16 
Coimbatore 30-80 150-200 0·17-0·26 
Dharmapuri 70-310 650-890 0·17-0·55 
Madurai 320-720 840-1150 0·23-0·46 
Salem 60-250 410-640 0·13-0·26 
Table 7: FSW district-specific syphilis treatment parameter ranges. Note that in 2007 there was a programmatic change in the rate of periodic presumptive treatment (PPT) from 3 to 6 months in all districts.  
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District 
Total number of clients per month stratified by FSW activity level Number of regular clients per 
month IBBA round 1 IBBA round 2 IBBA round 3 
Lower Higher Lower Higher Lower Higher Lower Higher 
Chitoor    27·0-29·8 68·4-75·4 17·1-19·6 54·9-65·1 NA NA 4·2-6·0 9·3-14·1 
East Godavari 24·3-28·0 81·7-97·4 20·0-25·1 75·4-102·0 NA NA 9·8-13·1 20·1-25·4 
Guntur     32·3-38·3 95·2-115·0 21·5-25·4 52·9-106·0 NA NA 4·4-8·5 9·3-28·0 
Hyderabad  12·3-14·4 41·3-48·6 17·2-24·9 52·3-59·9 NA NA 1·9-5·6 8·8-14·4 
Karimnagar 14·7-17·3 54·3-69·5 20·6-23·9 59·5-67·5 NA NA 6·0-8·4 11·0-14·4 
Prakasam   30·9-35·6 80·8-92·9 16·9-23·4 79·4-99·5 NA NA 9·7-14·0 21·0-27·8 
Vizag      32·4-37·2 87·1-96·6 20·8-23·8 64·1-77·4 NA NA 6·8-13·1 11·9-15·4 
Warangal   17·9-20·4 50·7-72·8 20·7-24·5 56·5-64·8 NA NA 3·4-8·7 12·9-18·5 
Bangalore  15·7-18·1 51·6-59·1 15·7-17·1 51·0-58·7 NA NA 6·5-8·3 13·9-17·8 
Belgaum    21·0-25·5 90·0-113·0 25·5-28·0 83·2-97·4 19·6-22·0 66·8-84·7 8·2-11·2 17·6-21·9 
Bellary    12·1-15·9 70·1-101·0 25·3-28·8 98·2-169·0 16·6-18·3 55·2-91·1 8·1-12·1 17·4-25·6 
Mysore     13·6-15·4 53·1-61·5 15·4-17·1 52·9-65·0 13·8-15·2 41·7-49·7 3·1-4·5 4·1-8·3 
Shimoga    9·89-11·1 44·9-54·4 19·5-22·1 52·5-58·8 NA NA 4·0-5·1 8·1-13·4 
Kolhapur   10·8-18·0 68·3-209·0 25·3-30·4 70·6-92·4 NA NA 2·8-5·5 6·2-13·3 
Mumbai 12·5-16·6 61·8-84·2 12·9-16·2 61·1-74·7 NA NA 2·4-4·2 6·7-11·9 
Parbhani   13·4-16·6 52·2-100·0 18·0-23·2 70·2-121·0 NA NA 6·6-8·7 9·3-10·9 
Pune 26·3-31·4 92·5-109·0 16·9-22·2 68·2-86·0 NA NA 3·3-5·5 4·6-16·0 
Thane 22·2-26·8 70·6-80·2 18·2-23·6 81·6-97·8 NA NA 4·2-6·9 8·9-11·1 
Yevatmal   39·8-51·4 126·0-218·0 34·2-43·0 142·0-192·0 NA NA 5·2-7·5 6·9-9·3 
Chennai    15·3-17·5 41·9-47·1 15·0-16·8 44·4-51·7 NA NA 7·6-10·4 11·3-14·4 
Coimbatore 15·3-17·8 47·7-54·2 7·22-10·3 32·4-37·3 NA NA 3·6-5·3 11·3-14·1 
Dharmapuri 27·3-31·8 73·0-88·9 8·48-10·8 41·3-51·5 NA NA 5·2-8·1 12·8-18·0 
Madurai    14·6-17·8 46·6-56·7 12·0-15·7 38·8-45·7 NA NA 6·3-9·6 9·8-15·7 
Salem      14·1-17·5 47·9-59·5 8·62-11·1 30·3-40·9 NA NA 5·6-8·8 10·3-16·4 
Table 8: FSW district-specific overall number of clients, and number of regular clients. The total number of clients includes both regular and occasional clients.  
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District Proportion 
of clients 
who are 
lower 
activity 
Duration as clients 
by activity level 
Number of FSW 
visited per month by 
activity level 
% of clients who have 
long-term partner by 
time buying sex 
Duration 
with long-
term partner 
Number of sex 
acts per month 
with long-term 
partner 
% condom 
use with 
long-term 
partner Lower Higher Lower Higher 0-4 years 5+ years 
East Godavari 0·54-0·64 110-142 171-247 1·4-1·6 4·2-5·8 29·4-51·9 74·4-85·8 219-260 11·7-15·8 2·8-10·1 
Guntur     0·52-0·69 77-97 148-207 1·3-1·4 2·8-3·9 25·3-61·9 82·7-94·1 228-296 13·0-18·7 2·8-14·6 
Hyderabad  0·62-0·77 78-96 54-73 1·2-1·6 3·2-4·0 22·5-68·2 60·2-94·4 161-188 10·7-12·6 0·0-4·0 
Vizag      0·70-0·82 86-106 123-187 1·4-1·5 4·2-5·4 24·7-49·0 68·3-82·6 220-288 8·0-11·8 1·6-5·9 
Warangal   0·53-0·76 71-88 45-59 1·2-1·5 2·7-5·7 16·8-36·1 45·1-86·7 217-285 12·0-16·3 1·4-6·3 
Bangalore  0·52-0·65 102-123 125-159 1·0 2·4-3·3 37·8-55·8 76·0-86·1 213-270 8·0-9·9 8·6-16·6 
Belgaum    0·58-0·69 95-120 106-145 1·0 2·3-2·8 32·4-49·8 80·9-90·7 184-235 9·5-11·7 4·7-13·3 
Bellary    0·40-0·54 91-119 112-147 1·0 2·4-2·7 36·9-59·1 82·5-92·6 185-243 10·4-13·6 3·0-9·4 
Mysore     0·50-0·60 139-185 158-218 1·7-2·0 4·3-4·9 55·3-73·7 86·3-93·0 142-262* 5·8-15·8* 2·0-13·9* 
Shimoga    0·73-0·82 131-165 102-150 1·0 2·2-2·5 24·9-44·7 80·6-90·0 216-280 9·3-10·8 2·0-6·4 
Mumbai 0·47-0·66 119-158 104-141 1·2-1·5 1·6-2·0 36·8-66·4 60·6-80·6 195-316 4·2-7·4 1·0-8·0 
Parbhani   0·56-0·75 93-117 104-144 1·4-1·7 2·0-2·6 27·0-57·0 78·9-93·9 154-210 8·6-12·7 3·5-11·7 
Pune 0·64-0·80 81-100 96-138 1·1-1·3 2·5-3·2 54·5-85·9 74·4-92·5 159-207 9·0-11·8 2·3-7·9 
Yevatmal   0·52-0·68 89-112 110-149 1·2-1·5 2·7-3·5 76·7-99·8 89·2-99·6 165-217 9·0-12·6 6·1-17·4 
Chennai    0·55-0·71 149-196 197-299 1·7-1·9 2·8-3·3 34·5-56·7 74·9-92·0 182-276 6·4-7·4 0·9-5·1 
Madurai    0·54-0·74 154-204 101-139 1·3-1·6 2·6-3·2 20·4-48·6 72·4-89·6 222-285 7·5-9·0 0·0-12·3 
Salem 0·45-0·66 65-82 80-104 1·5-2·1 2·4-3·1 30·8-67·7 79·2-99·5 120-165 6·0-7·7 6·4-21·4 
Districts without client IBBA 0·47-0·77 73-176 51-240 1·0-1·8 1·8-5·0 35·0-97·0 67·0-100 142-262 5·8-15·8 2·0-13·9 
Table 9: Prior ranges for client model parameters. All durations are in months.  
* In Mysore the skip pattern for this question was incorrectly applied, so the range for non-client-IBBA districts was used for this parameter. 
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District Duration 
as high-
risk MSM 
Number of 
occasional 
MSM 
partners of 
high-risk 
MSM 
% of MSM having a long-
term MSM partner Duration of 
partnerships 
with long-term 
MSM partner 
% of MSM with a long-
term female partner 
% of MSM visiting 
FSWs 
Number 
of FSW 
seen per 
month 
% 
circumcised 
High-risk Low-risk High-risk Low-risk High-risk Low-risk 
East 
Godavari 133-180 7·8-11·1 76·5-91·4 67·1-82·8 55·5-82·6 0·0-7·9 55·1-69·7 0 38·1-50·7 1·4-3·7 1·9-6·9 
Guntur     157-213 6·2-8·5 72·8-100 26·8-40·2 70·7-96·2 0·0-30·4 58·4-72·2 0·0-9·1 56·2-69·0 1·3-3·4 14·4-25·9 
Hyderabad  138-178 13·2-18·1 0 37·4-56·5 23·6-46·8 0 34·4-51·9 0 37·4-56·5 1·2-3·4 13·5-23·9 
Vizag      138-194 22·5-25·8 99·2-100 94·6-100 46·9-61·6 0·0-0·9 58·2-76·4 0 32·4-52·4 1·4-3·8 0·1-2·3 
Bangalore  183-236 3·6-10·0 33·5-51·3 30·6-54·7 76·3-118·0 1·0-10·1 12·3-37·0 4·5-15·2 11·2-30·9 1·0-3·2 10·2-19·0 
Belgaum    202-254 3·9-7·4 35·3-48·7 36·5-61·5 115·0-179·0 45·6-62·1 70·6-90·8 7·8-17·8 7·97-32·7 1·0-2·8 10·5-22·4 
Bellary    202-254 5·5-13·0 30·8-47·5 35·1-51·2 83·8-243·0 20·3-37·8 40·4-58·2 0·4-24·2 15·4-30·0 0·8-2·7 10·4-33·6 
Mysore     202-254 6·2-10·9 54·2-71·5 35·1-51·2 74·8-130·0 0·5-8·3 40·4-58·2 2·2-11·5 15·4-30·0 0·0-2·6 7·6-22·4 
Shimoga    202-254 3·2-7·3 17·6-37·8 35·1-51·2 64·7-131·0 25·0-54·1 40·4-58·2 11·2-31·2 15·4-30·0 1·0-2·5 11·0-34·7 
Mumbai 97·4-128 6·2-10·2 49·9-64·1 44·6-61·3 58·3-81·4 3·9-11·7 9·4-25·8 2·1-10·7 18·2-37·8 1·2-2·0 25·8-40·0 
Pune 124-174 13·3-25·1 53·8-71·0 31·2-54·1 63·9-98·9 2·3-11·2 13·7-32·8 2·1-11·9 29·8-50·4 1·1-3·1 12·0-29·9 
Chennai    213-276 16·1-21·8 65·3-78·6 39·0-89·4 59·6-81·6 8·0-17·5 0-36·6 10·6-23·7 33·3-85·3 1·7-2·6 4·8-17·1 
Coimbatore 173-223 9·8-13·6 76·8-88·1 85·0-97·0 73·7-96·7 13·8-23·7 36·3-64·1 1·8-6·7 8·4-29·6 1·0-3·0 3·9-10·3 
Madurai    242-317 16·4-20·7 70·9-84·0 63·3-88·0 71·4-116·0 9·6-25·8 8·7-30·6 1·0-5·2 6·8-25·4 1·2-2·0 4·0-10·3 
Salem      183-235 10·6-15·1 78·4-90·0 46·3-95·2 78·8-106·0 18·2-33·9 0-19·0 7·1-22·5 11·2-63·1 1·5-3·1 3·6-10·0 
Table 10: MSM sexual behaviour parameter ranges used in model. All durations are in months. In all districts: low-risk MSM are taken to spend 138-174 months as MSM before ceasing MSM sexual activity; 
MSM with regular MSM partners have 13-19 sex acts with that partner per month. 
 
  
30 
 
 
District 
Condom use with occasional MSM partners 
% of acts for 
which 
condom 
breaks per 
month 
Fraction 
reduction in 
condom use 
with regular 
MSM partners 
compared to 
occasional 
MSM partners 
% of high-
risk MSM 
getting 
Avahan 
treatment 
for syphilis 
Delay  for 
high-risk 
MSM getting 
Avahan 
syphilis 
treatment 
Number of MSM 
receiving PPT 
Annual % 
increase in 
condom use 
before 
Avahan 
% condom 
use at start 
of Avahan 
% condom 
use at IBBA 
round 1 
% condom 
use at IBBA 
round 2 
Before 
Jan 2007 
After Jan 
2007 
East 
Godavari 1·3-9·6 12·6-53·5 86·7-99·2 98·6-100 0·5-1·2 0·87 65-95 0·99-1·97 440-550 170-350 
Guntur     0·0-17·8 29·8-71·7 65·4-84·4 93·4-100 0·7-1·9 0·79 0 0·99-1·97 950-1050 110-330 
Hyderabad  8·9-17·3 33·4-76·6 85·2-98·5 99·5-100 1·0-1·6 0·74 0-45 0·05-0·15 0 0 
Vizag      0·0-26·2 0-100 87·3-95·7 88·2-100 0·5-1·0 0·95 93-100 0·02-0·07 730-800 50-180 
Bangalore  4·6-7·3 41·5-58·1 71·4-84·7 97·4-100 2·3-4·0 0·99 0-17 0·50-1·90 430-720 770-1340 
Belgaum    0·3-2·5 8·4-21·5 76·2-89·2 NA 2·8-4·8 1·0 3-20 1·51-2·06 10-30 220-330 
Bellary    0·7-3·7 3·2-21·2 65·7-89·9 NA 1·7-2·9 1·0 0 0·18-1·11 60-130 10-40 
Mysore     1·7-4·1 9·6-25·9 81·6-96·0 NA 1·8-3·2 0·95 0-13 0·56-1·28 20-60 140-230 
Shimoga    0·0-2·5 3·7-29·9 70·8-87·9 NA 3·0-5·2 1·0 0 0·81-2·27 30-40 0-20 
Mumbai 2·1-11·3 22·8-61·1 78·4-92·5 95·1-100 2·3-5·2 0·82 31-61 0·08-0·56 150-220 150-220 
Pune 3·8-15·1 55·4-97·2 66·9-90·9 96·6-100 1·5-2·9 0·87 0-17 0·12-0·37 30-50 200-860 
Chennai    2·6-9·5 8·0-51·3 76·0-91·4 94·0-99·5 1·5-2·3 0·91 8-78 0·16-0·27 280-430 410-460 
Coimbatore 0·0-5·3 0-24·4 78·3-90·1 97·6-99·9 0·9-2·3 0·94 31-100 0·08-0·23 190-390 150-320 
Madurai    6·3-12·3 27·4-74·5 76·9-89·5 95·5-100 0·6-1·7 0·82 41-78 0·10-0·20 110-270 160-190 
Salem      0·2-1·4 0·8-8·1 63·3-83·0 93·5-100 0·4-2·1 0·87 42-100 0·09-0·16 20-60 140-230 
Table 11: MSM district-specific condom use and syphilis treatment parameters. 
 
Mumbai Pune Thane 
Brothel-based: 29·3% Brothel-based 63·6% Brothel-based: 25·7% 
Street/home-based: 21·1% Non-brothel-based: 36·4% Street/home-based: 74·3% 
Bar-based: 49·6%   
Table 12: Percentage of FSWs by typology in districts where there was more than 1 FSW survey in each round.  
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District FSW R1 Client R1 Client R2 MSM R1 MSM R2 
HIV HSV-2 HT syphilis HIV HSV-2 HT syphilis HIV HIV HSV-2 HT syphilis HIV 
Chitoor 4·8-11·3 66·7-94·8 0·7-5·2 NA NA NA NA 
East Godavari 20·0-32·5 78·9-98·6 0·8-3·5 4·8-11·8 23·7-65·8 0-3·1 4·1-15·1 24·1-47·7 51·5-100 1·1-11·2 6·7-32·4 
Guntur 16·4-26·2 74·8-96·1 2·5-7·4 3·7-9·6 56·3-90·3 1·3-5·8 2·2-12·1 12·5-46·1 9·5-100 0-21·9 18·0-39·6 
Hyderabad 9·1-19·5 61·3-98·3 1·5-11·4 0·7-4·1 9·9-45·4 0-1·5 0-8·4 23·4-38·9 21·5-90·9 2·7-12·8 25·3-39·9 
Karimnagar 13·0-29·3 53·7-95·7 0·7-3·5 NA NA NA NA 
Prakasam 6·6-15·5 48·4-83·2 0-2·7 NA NA NA NA 
Vizag 9·4-19·1 40·2-77·0 0·9-4·7 4·3-11·8 80·5-99·1 0-1·7 1·3-8·9 2·7-13·5 0-73·1 0-2·3 1·2-9·9 
Warangal 6·3-15·4 37·5-74·0 1·9-8·0 0·6-12·9 3·9-33·8 0-10·9 0·7-4·9 NA NA 
Bangalore Urban 8·6-16·7 63·2-74·0 4·5-12·4 0·9-3·9 20·1-28·1 0·6-2·9 NA 14·0-26·8 27·2-41·8 3·6-12·4 12·6-24·8 
Belgaum 27·6-40·2 78·6-89·1 0·7-5·9 3·6-8·8 22·7-32·6 0·5-3·3 NA 3·9-14·2 41·6-57·8 1·2-7·8 NA 
Bellary 11·1-20·0 63·7-76·8 0·4-3·6 2·6-9·5 20·7-31·0 1·0-5·0 NA 19·9-43·7 46·2-70·4 3·6-15·9 NA 
Mysore 21·9-30·3 59·6-69·1 11·2-18·3 3·3-7·6 26·4-36·3 0·8-3·6 NA 14·8-30·1 50·3-72·1 6·1-22·4 NA 
Shimoga 6·3-13·1 53·2-65·8 0·7-4·8 0·9-5·1 20·0-31·4 0-1·1 NA 3·0-16·5 54·3-85·2 0-14·0 NA 
Kolhapur 23·7-42·4 59·5-100 4·8-21·3 NA NA NA NA 
Mumbai 12·3-20·1 55·6-79·6 0·5-2·3 5·6-12·6 10·2-43·4 0-1·6 1·8-9·5 10·2-20·3 24·6-74·9 0·7-5·0 0-24·3 
Parbhani 3·4-28·4 48·0-71·0 2·8-9·1 2·8-10·0 0-100 0-5·9 0-4·4 NA NA 
Pune 31·0-45·1 74·8-97·0 11·1-19·8 3·1-8·9 4·6-33·4 0·8-3·5 2·9-8·6 14·5-39·5 11·4-83·3 4·9-17·0 6·1-17·1 
Thane 5·8-14·2 30·7-64·9 0·4-3·7 NA NA NA NA 
Yevatmal 23·9-50·6 83·0-100 8·9-22·5 7·6-14·2 8·9-33·4 1·4-5·8 6·5-16·9 NA NA 
Chennai 0·4-4·1 8·0-61·3 0-1·3 0·7-3·4 6·4-32·8 0·4-3·3 NA* 2·1-7·9 28·4-38·4 0-0·1 4·8-15·9 
Coimbatore 2·7-9·9 42·0-79·0 0·2-2·7 NA NA 4·3-9·2 22·7-32·5 3·4-8·9 5·8-16·5 
Dharmapuri 7·0-17·8 53·7-90·5 0-3·4 NA NA NA NA 
Madurai 2·2-6·3 35·7-68·8 0-2·0 0·4-4·6 0-20·7 0-100 0-24·1 14·1-37·0 28·0-64·8 1·2-5·4 6·7-22·1 
Salem 7·8-17·4 33·8-91·9 0·3-3·2 1·1-7·3 7·5-37·1 0-0·7 0-1·7 2·5-10·7 2·5-27·5 0-9·1 0·9-8·6 
Table 13: HIV, HSV-2 and high-titre (HT) syphilis prevalence ranges  used for model fitting. High-titre syphilis is defined as RPR titre 1:8 or higher and TPHA positive. NA means no survey conducted for that 
risk group in that round. * In Chennai the client round 2 HIV prevalence was substantially higher than the round 1 client value and the FSW HIV prevalence, and was therefore not used in fitting. 
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District Factors adjusted for Prevalence ratio range 
FSW HIV prevalence ratio round 2 : round 1 
Chitoor Age, duration in sex work, literacy, marital status, sex work typology, ever been asked for anal sex 0·75-1·93 
East Godavari Literacy, marital status, sex work typology, ever been asked for anal sex 0·64-1·26 
Guntur Literacy, marital status, sex work typology, ever been asked for anal sex 0·44-1·00 
Hyderabad Literacy, marital status, ever been asked for anal sex 0·50-1·39 
Karimnagar Literacy, marital status, sex work typology, ever been asked for anal sex, localite status 0·19-0·50 
Prakasam Literacy, marital status, sex work typology, ever been asked for anal sex 0·47-1·33 
Vizag Age, duration in sex work, sex work typology, ever been asked for anal sex 0·48-1·13 
Warangal Marital status, sex work typology, ever been asked for anal sex, localite status 0·18-0·82 
Bangalore Sex work typology, age, marital status, education level, ever been asked for anal sex 0·57-1·29 
Belgaum None 0·58-1·02 
Bellary Age, duration in sex work, sex work typology, localite status 0·62-1·25 
Mysore None 0·79-1·22 
Shimoga None 0·53-1·45 
Kolhapur Age, duration in sex work, educational status, marital status, sex work typology, ever been asked for anal sex 0·65-1·17 
Mumbai Street-based: Age, duration in sex work, educational status, marital status, ever been asked for anal sex 
Brothel-based/bar girls: None 0·51-1·47 
Parbhani Education, marital status, sex work typology, ever been asked for anal sex, localite status 0·31-1·30 
Pune Brothel-based: Age, duration in sex work, educational status, marital status, sex work typology 
Non-brothel-based: None 0·52-0·97 
Thane Brothel-based: None; Street-based: Age, literacy, marital status 0·78-2·45 
Yevatmal Age, duration in sex work, educational status, marital status, ever been asked for anal sex 0·28-1·20 
Chennai Sex work typology and ever been asked for anal sex 0·23-1·72 
Coimbatore Literacy 0·54-2·50 
Dharmapuri Literacy, marital status, sex work typology, ever been asked for anal sex, localite status 0·30-1·10 
Madurai Literacy, sex work typology, localite status 0·90-2·67 
Salem Literacy, marital status, sex work typology, ever been asked for anal sex, localite status 0·63-1·74 
FSW HIV prevalence ratio round 3 : round 1 
Belgaum None 0·57-0·98 
Bellary Age, duration in sex work, sex work typology, localite status 0·28-0·72 
Mysore None 0·42-0·81 
Table 14: FSW HIV prevalence ratio ranges for all IBBA districts. Ratio is adjusted for variables listed in the table. Localite status = whether born in district of interview; sex work typology was determined by 
place of solicitation. 
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District 
FSW Round 1 FSW Round 2 FSW Round 3 
HIV  HSV-2 HT Tp HIV HSV-2 HT Tp HIV HSV-2 HT Tp 
Chitoor 8·1 (401) 80·8 (38) 2·9 (401) 10·5 (398) 55·0 (42) 0·5 (398) NA NA NA 
East Godavari 26·2 (422) 88·8 (42) 2·1 (422) 23·3 (401) 86·4 (49) 13·8 (401) NA NA NA 
Guntur 21·3 (405) 85·4 (36) 5·0 (405) 8·4 (405) 58·1 (54) 0·0 (405) NA NA NA 
Hyderabad 14·3 (399) 79·8 (39) 6·5 (399) 9·6 (401) 83·7 (34) 1·3 (401) NA NA NA 
Karimnagar 21·1 (412) 74·7 (51) 2·1 (412) 6·5 (402) 73·2 (31) 1·2 (402) NA NA NA 
Prakasam 11·1 (404) 65·8 (41) 0·9 (404) 13·4 (408) 72·5 (51) 0·0 (408) NA NA NA 
Vizag 14·2 (411) 58·6 (41) 2·8 (411) 18·2 (409) 60·7 (38) 4·2 (409) NA NA NA 
Warangal 10·8 (417) 55·7 (37) 4·9 (417) 15·0 (401) 34·4 (32) 1·5 (401) NA NA NA 
Bangalore 12·7 (673) 68·6 (648) 8·4 (649) 8·0 (750) NA 4·3 (680) NA NA NA 
Belgaum 33·9 (363) 83·9 (359) 3·3 (357) 27·3 (399) NA 2·9 (387) 22·2 (417) 72·2 (411) 1·1 (412) 
Bellary 15·6 (426) 70·2 (420) 2·0 (420) 14·1 (410) NA 4·8 (401) 6·3 (397) 57·2 (390) 3·2 (396) 
Mysore 26·1 (429) 64·4 (393) 14·8 (393) 24·3 (425) 78·6 (425) 3·1 (425) 10·9 (425) 67·3 (424) 5·2 (425) 
Shimoga 9·7 (389) 59·5 (386) 2·7 (386) 9·0 (406) NA 1·9 (403) NA NA NA 
Kolhapur 33·0 (115) 83·3 (12) 13·0 (115) 27·4 (190) 75·0 (20) 0·5 (190) NA NA NA 
Mumbai 16·2 (354) 67·7 (38) 1·4 (355) 19·1 (398) 74·6 (44) 2·0 (398) NA NA NA 
Parbhani 15·9 (353) 59·5 (42) 6·0 (353) 14·8 (303) 80·7 (31) 4·0 (303) NA NA NA 
Pune 38·0 (350) 86·7 (34) 15·4 (350) 20·9 (353) 77·8 (37) 5·3 (353) NA NA NA 
Yevatmal 37·2 (153) 100·0 (16) 15·7 (153) 26·8 (157) 87·5 (16) 7·6 (157) NA NA NA 
Chennai 2·2 (410) 34·6 (43) 0·6 (410) 2·4 (397) 50·4 (55) 0·0 (397) NA NA NA 
Coimbatore 6·3 (410) 60·5 (39) 1·4 (410) 6·3 (400) 62·8 (52) 0·1 (400) NA NA NA 
Dharmapuri 12·4 (408) 72·1 (44) 1·7 (408) 8·8 (406) 48·4 (57) 0·0 (406) NA NA NA 
Madurai 4·3 (402) 52·2 (40) 0·5 (401) 8·4 (396) 51·3 (49) 1·8 (396) NA NA NA 
Table 15: FSW prevalences and sample sizes for HIV, HSV-2 and high-titre syphilis (HT Tp) used in constructing likelihood weights. NA= not applicable. 
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District 
Client Round 1 Client Round 2 MSM Round 1 MSM Round 2 
HIV HSV-2 HT Tp HIV HSV-2 HT Tp HIV HSV-2 HT Tp HIV HSV-2 HT Tp 
Chitoor NA NA NA NA NA NA NA NA NA NA NA NA 
East Godavari 8·3 (409) 44·8 (43) 1·5 (409) 25·4 (399) 25·4 (45) 1·3 (401) 35·9 (115) 77·9 (10) 6·1 (115) 19·6 (182) 84·9 (47) 3·4 (182) 
Guntur 6·6 (401) 73·3 (40) 3·6 (401) 49·7 (406) 49·7 (40) 0·0 (406) 29·3 (43) 57·8 (6) 9·4 (42) 28·8 (204) 89·2 (26) 0·0 (204) 
Hyderabad 2·4 (406) 27·6 (40) 0·7 (406) 47·1 (400) 47·1 (62) 0·6 (400) 31·1 (160) 56·2 (19) 7·7 (160) 32·6 (293) 72·9 (23) 0·0 (293) 
Karimnagar NA NA NA NA NA NA NA NA NA NA NA NA 
Prakasam NA NA NA NA NA NA NA NA NA NA NA NA 
Vizag 8·0 (402) 89·8 (35) 0·8 (402) 25·3 (405) 25·3 (46) 1·3 (406) 8·1 (177) 26·3 (15) 1·1 (177) 5·5 (160) 11·4 (17) 2·1 (160) 
Warangal 6·7 (402) 18·9 (35) 4·8 (402) 29·5 (403) 29·5 (32) 0·1 (403) NA NA NA NA NA NA 
Bangalore 2·4 (680) 24·1 (634) 1·7 (630) NA NA NA 20·4 (232) 34·5 (221) 8·0 (221) 18·7 (306) 0·0 (307) 5·7 (252) 
Belgaum 6·2 (408) 27·6 (388) 1·9 (386) NA NA NA 9·1 (199) 49·7 (155) 4·5 (155) NA NA NA 
Bellary 6·0 (424) 25·8 (406) 2·3 (407) NA NA NA 31·8 (85) 58·3 (72) 9·7 (72) NA NA NA 
Mysore 5·4 (425) 31·4 (411) 2·2 (411) NA NA NA 22·4 (98) 61·2 (98) 14·3 (98) NA NA NA 
Shimoga 3·0 (426) 25·7 (421) 0·5 (421) NA NA NA 9·8 (82) 69·7 (76) 6·6 (76) NA NA NA 
Kolhapur NA NA NA NA NA NA NA NA NA NA NA NA 
Mumbai 9·1 (394) 26·8 (51) 0·7 (394) 34·8 (371) 34·8 (37) 2·8 (371) 15·3 (194) 49·8 (28) 2·8 (194) 11·2 (191) 5·2 (24) 0·0 (191) 
Parbhani 5·0 (404) 50·0 (0) 1·2 (404) 12·8 (395) 12·8 (43) 2·0 (395) NA NA NA NA NA NA 
Pune 6·0 (401) 81·0 (40) 2·1 (401) 19·2 (404) 19·2 (36) 2·1 (404) 27·0 (137) 47·4 (19) 10·9 (137) 11·6 (138) 21·1 (19) 2·2 (138) 
Yevatmal 10·5 (399) 27·4 (58) 3·3 (399) 23·1 (400) 23·1 (34) 1·8 (398) NA NA NA NA NA NA 
Chennai 2·0 (405) 19·6 (44) 1·8 (406) 23·6 (408) 23·6 (41) 3·5 (408) 5·0 (387) 33·4 (383) 0·0 (387) 10·4 (354) 24·3 (45) 2·7 (354) 
Coimbatore NA NA NA NA NA NA 6·7 (332) 27·6 (331) 6·1 (332) 11·2 (407) 16·4 (74) 5·2 (407) 
Dharmapuri NA NA NA NA NA NA NA NA NA NA NA NA 
Madurai 2·5 (400) 10·2 (40) 0 (401) 25·7 (402) 25·7 (67) 0·0 (402) 25·5 (338) 46·4 (30) 3·3 (338) 14·4 (406) 20·8 (48) 5·3 (405) 
Table 16: Client and MSM prevalences and sample sizes for HIV, HSV-2 and high-titre syphilis (HT Tp) used in constructing likelihood weights. NA= not applicable. 
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 Number of infections averted over 4 years Number of infections averted to 2013 
Variable Beta P value R2 Beta P value R2 
District context variables       
Date of start of Avahan -1586 0·269 0·064 -4464 0·253 0·072 
Whether Avahan was the first FSW intervention in the district 185.6 0·869 0·002 954.0 0.751 0.006 
Avahan was the main FSW intervention provider in the first year 2209 0·016 0·270 5260 0·035 0·224 
Mean ANC HIV prevalence in 2004-5 1079 0·983 0·000 33450 0·806 0·004 
Annual change in ANC HIV prevalence 2004-8 -7873 0·864 0·002 -53297 0·661 0·012 
Annual rate of population growth in district -7203 0·931 0·000 8162 0·970 0·000 
District in Andhra Pradesh 1084 0·265 0·065 2041 0·451 0·032 
District in Karnataka 328·0 0·771 0·005 1638 0·584 0·017 
District in Maharashtra -2122 0·047 0·192 -7222 0·008 0·329 
District in Tamil Nadu 570·6 0·677 0·009 4570 0·200 0·090 
Avahan cost variables       
Total year 1 cost of Avahan activities 0·0042 0·432 0·057 0·0122 0·376 0·079 
Total year 2 cost of Avahan activities 0·0005 0·527 0·021 0·0006 0·754 0·006 
Total year 3 cost of Avahan activities 0·0005 0·423 0·034 0·0009 0·604 0·015 
Total year 4 cost of Avahan activities 0·0006 0·345 0·047 0·0011 0·562 0·019 
Total 4 year cost of Avahan activities 0·0002 0·314 0·053 0·0004 0·494 0·026 
Size estimate variables       
FSW size estimate 0·3266 0·024 0·242 0·6454 0·113 0·134 
High-risk MSM size estimate 0·4502 0·306 0·104 1·584 0·160 0·187 
Brothel-based FSW size estimate -0·6212 0·273 0·063 -2·078 0·163 0·105 
Street-based FSW size estimate 0·6984 0·045 0·195 2·115 0·169 0·108 
Home-based FSW size estimate 0·3583 0·338 0·057 1·010 0·424 0·040 
Proportion of FSWs who are brothel-based -3146 0·134 0·115 -13903 0·107 0·145 
Proportion of FSWs who are street-based 171·6 0·927 0·001 3000 0·541 0·021 
Proportion of FSWs who are home-based 1282 0·445 0·033 3047 0·527 0·024 
Programmatic variables       
Average number of FSW contacted by programme per month in 2006 523·3 0·709 0·008 5086 0·186 0·095 
Average number of FSW contacted by programme per month in 2008 1694 0·268 0·064 3151 0·441 0·033 
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Average monthly number of condoms distributed in 2006 3·407 0·908 0·001 58·35 0·477 0·029 
Average monthly number of condoms distributed in 2008 13·07 0·532 0·021 12·30 0·826 0·003 
Average number of FSW seen  per month in Avahan clinics in 2006 -2980 0·523 0·022 -8872 0·483 0·028 
Average number of FSW seen  per month in Avahan clinics in 2008 -1970 0·566 0·018 -13393 0·131 0·122 
Mean number of FSWs on PPT 2·480 0·058 0·185 4·464 0·240 0·080 
Table 17: Univariate linear regression with number of infections averted over 4 years and to 2013 as the dependent variables.
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 Number of HIV infections averted over 4 years Number of HIV infections averted to 2013 
Variable Beta P-value Beta P-value 
FSW size estimate 0·332 0·004 0·739 0·015 
Avahan was the main FSW 
intervention provider in the 
first year 
1752 0·016 3925 0·040 
District in Maharashtra 
 
-1760 0·032 -6665 0·004 
Constant 568·3 
 
0·404 
 
3444 0·068 
Table 18: Multivariable regression model coefficients used for extrapolation to non-IBBA districts with number of infections averted over 4 years and to 2013 as the dependent variables. 
 
District Decrease in low-risk women incidence 
under intervention condom hypothesis 
Decrease in FSW incidence under 
intervention condom hypothesis  
FSW HIV incidence rate ratio between the 
intervention and control condom hypotheses 
after 4 years of intervention Over 4 years To 2013 Over 4 years To 2013 
Chitoor -130·8% 70·8% -0·5% 91·3% 0·18 
East 
Godavari 
49·1% 87·0% 76·2% 91·9% 
0·34 
Guntur 65·3% 93·0% 89·7% 98·2% 0·13 
Hyderabad 41·0% 95·1% 67·9% 93·4% 0·92 
Karimnagar 64·1% 92·6% 88·1% 97·5% 0·12 
Prakasam 48·9% 92·1% 80·9% 97·5% 0·14 
Vizag 66·6% 89·9% 91·7% 97·8% 0·11 
Warangal 64·5% 93·7% 90·5% 98·3% 0·10 
Bangalore 61·4% 86·5% 79·8% 91·7% 0·29 
Belgaum 52·2% 84·3% 62·4% 87·0% 0·53 
Bellary 52·5% 87·6% 64·9% 93·9% 0·32 
Mysore 60·1% 92·7% 68·4% 89·7% 0·35 
Shimoga 53·0% 85·1% 66·9% 86·5% 0·31 
Kolhapur 54·1% 87·3% 60·9% 88·1% 0·87 
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Mumbai 60·3% 89·6% 67·4% 92·2% 0·90 
Parbhani 62·2% 90·7% 80·6% 95·1% 0·44 
Pune 65·4% 90·4% 78·4% 95·5% 0·92 
Yevatmal 65·0% 90·8% 81·1% 94·0% 0·85 
Chennai 31·8% 80·9% 74·0% 93·2% 0·11 
Coimbatore -78·6% 71·0% 50·0% 95·4% 0·13 
Dharmapuri 52·3% 91·5% 87·9% 97·9% 0·08 
Madurai -28·3% 69·6% 46·1% 92·3% 0·09 
Table 19: Percentage change in incidence for low-risk women and FSWs over 4 and 10 years compared to the start of the intervention, and FSW incidence rate ratio between intervention 
and control condom hypotheses after 4 years.  
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Figure 1: FSW CCU trends and HIV prevalence for all modelled IBBA districts, ordered by state. Dark and light 
solid/dotted shaded areas represent 50% and 95% CrI of prevalence for intervention/control condom hypothesis. Prior 
ranges for intervention/control condom hypotheses CCU are shown as solid/dotted shaded areas, and solid/dotted thick 
lines represent median prior intervention/control condom hypothesis CCU. Solid/dotted thick lines represent median 
HIV prevalence for intervention/control condom hypotheses respectively. Error bars represent reported CCU levels and 
HIV prevalence in FSWs from IBBA surveys. 
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(a) 
 
(b) 
 
Figure 2: Scatterplots showing proportion of HIV infections averted over 4 years against: (a) increase in FSW CCU over 
the course of the intervention; and (b) % of FSW reporting CCU at the start of the intervention. Green diamonds 
represent districts with strong/moderate evidence from hypothesis testing, and red squares represent districts with 
weak evidence of intervention impact. Also shown is the best-fit line.  
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